Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Updates log 26 May 2026: First publication
This D-retro-inverso peptide specifically disrupts the FOXO4-p53 protein interaction that maintains senescent cell viability, providing researchers with a sophisticated tool for investigating cellular senescence biology and its role in aging processes
Individuals with Wilson's disease or copper metabolism disorders should not receive copper-containing injectable preparations
Cagrilintide vs tirzepatide Tirzepatide is a dual GIP/GLP-1 agonist that produces the highest monotherapy weight loss results currently available, approximately 22.5% at the maximum dose
US$ 21.35
US$ 25.60
US$ 25.57
US$ 27.65
